After nearly two weeks of silence, Israel Makov, the outgoing CEO of Teva Pharmaceuticals, on Monday denied all speculation and rumors surrounding the reasoning for his surprise departure from the company in interviews that were given exclusively to the Hebrew press.
Rufuting rumors that Teva chairman Eli Hurvitz had been infuriated by Makov's refusal to promote his son, VP Haim Hurvitz, to CEO, Makov said Hurvitz did not talk to him about that business and that he had excellent relations with Hurvitz's son. Additionally, Makov denied reports of disagreements with Eli Hurvitz and of tense relations he allegedly had with the company's board of directors.
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>